Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf

Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by macroglossia, hemihyperplasia, omphalocele, neonatal hypoglycemia, macrosomia, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, kidney abnormalities (e.g., medullary dysplasia, nephrocalcinosis, and medullary sponge kidney), and ear creases / posterior helical ear pits. BWS is considered a clinical spectrum, in which affected individuals may have many or only one or two of the characteristic clinical features. Although most individuals with BWS show rapid growth in late fetal development and early childhood, growth rate usually slows by age seven to eight years. Adult heights are typically within the normal range. Hemihyperplasia (also known as lateralized overgrowth) is often appreciated at birth and may become more or less evident over time. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues. Hemihyperplasia may be limited to one side of the body (ipsilateral) or involve opposite sides of the body (contralateral). Macroglossia is generally present at birth and can obstruct breathing or interfere with feeding in infants. Neonatal hypoglycemia occurs in approximately 50% of infants with BWS; most episodes are mild and transient. However, in some cases, persistent hypoglycemia due to hyperinsulinism may require consultation with an endocrinologist for therapeutic intervention. With respect to the increased risk for embryonal tumor development, the risk for Wilms tumor appears to be concentrated in the first seven years of life, whereas the risk for developing hepatoblastoma is concentrated in the first three to four years of life. Cognitive and neurobehavioral development is usually normal. After childhood, prognosis is generally favorable, although some adults experience issues requiring medical management (e.g., for renal or skeletal concerns).

Genome-wide methylation profiling of Beckwith-Wiedemann syndrome

Cancers, Free Full-Text

Clinical spectrum and management of imprinting disorders

Clinical and molecular diagnosis, screening and management of

Beckwith-Wiedemann syndrome: Causes, symptoms, treatment, and more

Characterization of the Beckwith‐Wiedemann spectrum: Diagnosis and

Beckwith–Wiedemann syndrome European Journal of Human Genetics

Beckwith-Wiedemann Syndrome - an overview

Uniparental Disomy of Chromosome 11 disease: Malacards - Research

Representative cardinal and suggestive features of Beckwith

Uniparental disomy in a population of 32,067 clinical exome trios

Beckwith-Weidemann syndrome with IC2 (KvDMR1) hypomethylation

Beckwith-Wiedemann Syndrome by Carlos Jimenez

Beckwith–Wiedemann and IMAGe syndromes: two very different disea

Figure 2. [Causes of Beckwith-Wiedemann syndrome by genetic